Jeffrey P. Bruce

Colorectal Cancer Cells Enter a Diapause-like DTP State to Survive Chemotherapy

Sumaiyah K. Rehman, Jennifer Haynes, Évelyne Collignon et al. · Cell · 2021 · 497 citations · Full text

Medicine, Cancer Biology, Oncology +13

Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial

Stéphanie Lheureux, Mihaela Cristea, Jeffrey P. Bruce et al. · The Lancet · 2021 · 211 citations · Full text

Medicine, Oncology, Pharmacology +10

The genomic landscape of schwannoma

Sameer Agnihotri, Shahrzad Jalali, Mark R. Wilson et al. · Nature Genetics · 2016 · 188 citations

Medicine, Genetics, Molecular Genetics +12

EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression

Stéphanie Lheureux, Ana Oaknin, Swati Garg et al. · Clinical Cancer Research · 2020 · 132 citations · Full text

Medicine, Oncology, Pharmacology +16

Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity

S.Y. Cindy Yang, Scott Lien, Ben X. Wang et al. · Nature Communications · 2021 · 128 citations · Full text

Life Sciences, Immunology, Oncology +17